{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:25:32Z","timestamp":1767115532120,"version":"3.46.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.7759\/cureus.98251","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:46:30Z","timestamp":1764611190000},"source":"Crossref","is-referenced-by-count":1,"title":["Conceptualization of Risk Stratification Using Large Language Models to Predict Severe Mycoplasma pneumoniae Pneumonia"],"prefix":"10.7759","author":[{"given":"Adebanke","family":"Adeyemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swapan","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol EJ","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019, 25:44-56. 10.1038\/s41591-018-0300-7","journal-title":"Nat Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/amajethics.2019.167","article-title":"Can AI help reduce disparities in general medical and mental health care?","volume":"21","author":"Chen IY","year":"2019","unstructured":"Chen IY, Szolovits P, Ghassemi M. Can AI help reduce disparities in general medical and mental health care?. AMA J Ethics. 2019, 21:E167-79. 10.1001\/amajethics.2019.167","journal-title":"AMA J Ethics"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2008.00129.x","article-title":"Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections","volume":"32","author":"Atkinson TP","year":"2008","unstructured":"Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008, 32:956-73. 10.1111\/j.1574-6976.2008.00129.x","journal-title":"FEMS Microbiol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites KB","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the respiratory tract and beyond. Clin Microbiol Rev. 2017, 30:747-809. 10.1128\/CMR.00114-16","journal-title":"Clin Microbiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00800","article-title":"Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia","volume":"7","author":"Izumikawa K","year":"2016","unstructured":"Izumikawa K. Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia. Front Microbiol. 2016, 7:800. 10.3389\/fmicb.2016.00800","journal-title":"Front Microbiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12519-018-0162-6","article-title":"Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children","volume":"14","author":"Wang X","year":"2018","unstructured":"Wang X, Zhong LJ, Chen ZM, Zhou YL, Ye B, Zhang YY. Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children. World J Pediatr. 2018, 14:344-9. 10.1007\/s12519-018-0162-6","journal-title":"World J Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156465","article-title":"The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zhang Y","year":"2016","unstructured":"Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in children. PLoS One. 2016, 11:e0156465. 10.1371\/journal.pone.0156465","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-74251-5","article-title":"Predicting the severity of mycoplasma pneumoniae pneumonia in pediatric and adult patients: a multicenter study","volume":"14","author":"Zhuo LY","year":"2024","unstructured":"Zhuo LY, Hao JW, Song ZJ, et al.. Predicting the severity of mycoplasma pneumoniae pneumonia in pediatric and adult patients: a multicenter study. Sci Rep. 2024, 14:22978. 10.1038\/s41598-024-74251-5","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024894","article-title":"The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: a meta-analysis","volume":"100","author":"Gong H","year":"2021","unstructured":"Gong H, Sun B, Chen Y, Chen H. The risk factors of children acquiring refractory mycoplasma pneumoniae pneumonia: a meta-analysis. Medicine (Baltimore). 2021, 100:e24894. 10.1097\/MD.0000000000024894","journal-title":"Medicine (Baltimore)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i22.4940","article-title":"Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma severity","volume":"12","author":"Wang LP","year":"2024","unstructured":"Wang LP, Hu ZH, Jiang JS, Jin J. Serum inflammatory markers in children with Mycoplasma pneumoniae pneumonia and their predictive value for mycoplasma severity. World J Clin Cases. 2024, 12:4940-6. 10.12998\/wjcc.v12.i22.4940","journal-title":"World J Clin Cases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1489389","article-title":"Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study","volume":"12","author":"Li Y","year":"2024","unstructured":"Li Y, Liu Y, Chen X, et al.. Clinical characteristics and predictive indictors of macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective study. Front Pediatr. 2024, 12:1489389. 10.3389\/fped.2024.1489389","journal-title":"Front Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4774-9","article-title":"Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children's hospital","volume":"20","author":"Liu J","year":"2020","unstructured":"Liu J, He R, Wu R, et al.. Mycoplasma pneumoniae pneumonia associated thrombosis at Beijing Children's hospital. BMC Infect Dis. 2020, 20:51. 10.1186\/s12879-020-4774-9","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ped4.12469","article-title":"Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023)","volume":"9","author":"Subspecialty Group of Respiratory","year":"2025","unstructured":"Subspecialty Group of Respiratory, the Society of Pediatrics, Chinese Medical Association; China National Clinical Research Center of Respiratory Diseases; Editorial Board, Chinese Journal of Pediatrics. Evidence-based guideline for the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2023). Pediatr Investig. 2025, 9:1-11. 10.1002\/ped4.12469","journal-title":"Pediatr Investig"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain S","year":"2015","unstructured":"Jain S, Williams DJ, Arnold SR, et al.. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015, 372:835-45. 10.1056\/NEJMoa1405870","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy419","article-title":"Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia","volume":"68","author":"Kutty PK","year":"2019","unstructured":"Kutty PK, Jain S, Taylor TH, et al.. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin Infect Dis. 2019, 68:5-12. 10.1093\/cid\/ciy419","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-025-03262-1","article-title":"Development and validation of an early diagnosis model for severe mycoplasma pneumonia in children based on interpretable machine learning","volume":"26","author":"Xie S","year":"2025","unstructured":"Xie S, Wu M, Shang Y, et al.. Development and validation of an early diagnosis model for severe mycoplasma pneumonia in children based on interpretable machine learning. Respir Res. 2025, 26:182. 10.1186\/s12931-025-03262-1","journal-title":"Respir Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/AIp2500015","article-title":"Redefining bias audits for generative AI in health care","volume":"2","author":"Chen IY","year":"2025","unstructured":"Chen IY, Alsentzer E. Redefining bias audits for generative AI in health care. NEJM AI. 2025, 2:10.1056\/AIp2500015","journal-title":"NEJM AI"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/aidbp2401267","article-title":"A novel playbook for pragmatic trial operations to monitor and evaluate ambient artificial intelligence in clinical practice","volume":"2","author":"Afshar M","year":"2025","unstructured":"Afshar M, Resnik F, Baumann MR, et al.. A novel playbook for pragmatic trial operations to monitor and evaluate ambient artificial intelligence in clinical practice. NEJM AI. 2025, 2:10.1056\/aidbp2401267","journal-title":"NEJM AI"},{"key":"ref19","unstructured":"Advancing AI across academic medicine resource collection. (2024). Accessed. September 23, 2025: https:\/\/www.aamc.org\/about-us\/mission-areas\/medical-education\/advancing-ai-across-academic-medicine-resource-collection."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419705-conceptualization-of-risk-stratification-using-large-language-models-to-predict-severe-mycoplasma-pneumoniae-pneumonia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T17:46:31Z","timestamp":1764611191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419705-conceptualization-of-risk-stratification-using-large-language-models-to-predict-severe-mycoplasma-pneumoniae-pneumonia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.98251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}